Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.

American journal of surgery - 1 Sept 2011

Howard-McNatt Marissa, Schroll Rebecca W, Hurt Gail J, Levine Edward A

Abstract excerpt

BACKGROUND: Determination of BRCA1 and 2 mutation carrier status is important. Although BRCA carriers are offered bilateral mastectomy and oophorectomy, most who test negative decline. Some women choose contralateral prophylactic mastectomy (CPM) at the time of their breast cancer diagnosis despite testing negative. METHODS: A total of 110 women with breast cancer received genetic testing before surgical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Disease-Free Survival
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Testing

Share to Mammaplasty

Share to North Carolina

Share to Secondary Prevention

Source

Identifiers

PMID: 21871984
DOI: 10.1016/j.amjsurg.2011.04.001

Genes

CPM
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.PMID 21871984Read ↗

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.Semantic proximity Read ↗

Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.Semantic proximity Read ↗

Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.Semantic proximity Read ↗

Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.Semantic proximity Read ↗

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.Semantic proximity Read ↗

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.Semantic proximity Read ↗

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.Semantic proximity Read ↗

Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Semantic proximity Read ↗

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.Semantic proximity Read ↗

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.Semantic proximity Read ↗

Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.Semantic proximity Read ↗

Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.